Article
T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications.
Blood - 1 Jul 1990
Anderson K C, Soiffer R, DeLage R, Takvorian T, Freedman A S, Rabinowe S L, Nadler L M, Dear K, Heflin L, Mauch P
Abstract excerpt
Fourteen patients with T-cell-derived leukemia and lymphoma underwent high-dose chemoradiotherapy and anti-T-cell monoclonal antibody-treated autologous bone marrow transplantation (ABMT). All patients were either in sensitive relapse or had adverse prognostic features, and five patients had a hi...
Topics
- Adult
- Aged
- Bone Marrow Transplantation
- Cyclophosphamide
- Female
- Graft vs Host Disease
- Hepatitis
- Herpes Zoster
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Non-Hodgkin
- Lymphoproliferative Disorders
- Male
- Middle Aged
- Phenotype
- Pneumonia, Pneumocystis
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Transplantation, Autologous